BIOLOGY.DIGITAL
10x Genomics Launches Xenium Prime 5K Pan-Tissue Spatial Transcriptomics Assay

Image: GEN

Launch

10x Genomics Launches Xenium Prime 5K Pan-Tissue Spatial Transcriptomics Assay

August 5, 2026 • Source: GEN

10x Genomics expanded its spatial biology portfolio with Xenium Prime 5K, enabling subcellular in situ profiling of 5,000 genes across FFPE and fresh-frozen human and mouse tissues.

**Executive Summary (2026-08-05):** 10x Genomics expanded its spatial biology portfolio with Xenium Prime 5K, enabling subcellular in situ profiling of 5,000 genes across FFPE and fresh-frozen human and mouse tissues. Source: GEN.

Technical Architecture & R&D Impact

Paired with automated multimodal cell segmentation and Cloud Analysis pipelines, Xenium Prime 5K increases transcript capture sensitivity while preserving tissue morphology for same-section H&E and immunofluorescence protein co-detection in oncology translational research.

Enterprise Biopharma Procurement Takeaways

For computational biology leads, medicinal chemists, and R&D IT architects, this milestone underscores the rapid convergence of wet-lab experimental validation and scalable cloud foundation models during H2 2026. Teams evaluating vendors in the Launch category should benchmark API reproducibility, GxP audit readiness, and zero-data-retention VPC deployment terms.

Related Products

Published August 5, 2026

More News

Last updated: August 5, 2026

Ask AI